Funding Opportunities
The Emory CFAR uses five direct and indirect funding mechanisms to facilitate HIV/AIDS research and the dissemination of findings based on research. These are described below, with links on the left to more information about each.
CFAR03 PROGRAM
The CFAR03 Program is intended to help move CFAR junior faculty toward independent investigator status in HIV/AIDS research at NIH. It is modeled on the NIH R03 program and is designed to provide support for new investigators doing research projects that can be carried out in a short period of time with limited resources. Applications are accepted for review twice a year.
Deadlines: February 1 and September 1.
I-CFAR03 PROGRAM
The International CFAR03 (I-CFAR03) Program provides funding for collaborations between CFAR investigators and former Fellows of two Fogarty International Center-funded programs: the Emory AIDS International Training and Reserach Program (AITRP) and the Emory-Georgia Tuberculosis Research Training Program (E-GTbRTP). The I-CFAR03 is designed to help Emory Fogarty graduates who have returned to their home countries collect preliminary data preparatory to submitting applications for NIH funding. Applications are accepted for review twice a year.
Deadlines: February 1 and September 1.
MICRO GRANTS PROGRAM
The Micro Grants Program is intended to remove obstacles to HIV/AIDS research productivity or career advancement by providing small but crucial resources that cannot easily or immediately be obtained through other funding mechanisms. This program provides reimbursement or direct purchases of up to $2,000 per approved request.
Applications have a rolling deadline.
NIH CFAR SUPPLEMENTAL FUNDING
As funds become available, the NIH provides the CFAR network with opportunities to apply for competitive supplements to the CFAR base grant. All Emory CFAR investigators are eligible to apply as project directors for NIH CFAR supplements.A notice will be sent to the CFAR Investigator listserv the next time that the NIH CFAR announces a call for supplement applications.